Delivery Order SPE2DB24D2003-SPE2DB24FXFQ3

Award Date 7/17/24
Potential Completion Date 7/18/24
Potential Value $1.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of Cosentyx (secukinumab) 300mg dose syringes to the Defense Logistics Agency (DLA). The $11,139.37 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, through the company's Indefinite Delivery Contract (IDC) with the DLA valued at $999,999,999. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military...
This federal contract award is for the pharmaceutical product Cosentyx 300 mg in pre-filled syringes. It was awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,043.92 fixed-price delivery order contract has a period of performance through July 31, 2023. The contract is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical,...
This federal contract award is for the delivery of Cosentyx (secukinumab) 300 mg dosage injectable medication. The contract was awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, and does not have a set-aside designation. The contract is a Delivery Order with a Firm Fixed Price pricing type, valued at $4,680.45, and has an ultimate completion date of September 20, 2024. AmerisourceBergen holds a larger Indefinite Delivery Contract...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of one of the world's largest pharmaceutical distribution companies, is for the delivery of the prescription drug Cosentyx (secukinumab) 300mg dose in 2 pre-filled syringes. The $9,131.70 contract is a firm fixed-price delivery order issued by the Defense Logistics Agency (DLA), a defense agency, and does not have a set-aside designation. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of the specialty medication Cosentyx (secukinumab) in 300mg doses. The $9,447.36 firm-fixed-price delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical supplies to...
This federal contract award is for the delivery of Cosentyx 150 mg/ml syringes to the Defense Logistics Agency (DLA). The contract, valued at $12,175.60, is a firm fixed-price delivery order awarded to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award has an ultimate completion date of September 6, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Cosentyx (secukinumab) 300 mg prefilled syringes. The award is under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between AmerisourceBergen and the DLA Troop Support Medical, which serves as a primary vehicle for providing a wide range of pharmaceutical products and medical supplies to support military healthcare...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,594.48 firm fixed-price delivery order is for the supply of Cosentyx (Secukinumab) 300mg dose-2 prefilled syringes. The award is associated with a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026....
This federal contract award is for the delivery of Cosentyx 300 mg dose-2 syringes to the Defense Logistics Agency (DLA). The $4,052.90 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on November 17, 2022, with a completion date of November 18, 2022. The contract has no set-aside designation, indicating open competition. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This contract award is for the pharmaceutical product Cosentyx (Secukinumab) 300mg dose, procured by the Defense Logistics Agency (DLA) through a firm-fixed price delivery order. The $15,219.50 award was made to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on October 4, 2024 with a period of performance through October 7, 2024. This delivery order is issued under AmerisourceBergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
  • SPE2DB24D2003
    Indefinite Delivery Contract
  • SPE2DB24D2003-SPE2DB24FXFQ3
    Delivery Order

This federal contract award is for the delivery of the pharmaceutical product Cosentyx (secukinumab) in 300 mg dose prefilled syringes. The contract, valued at $1,521.95, was awarded to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). This is a firm fixed-price delivery order under a larger indefinite delivery contract (IDC) between AmerisourceBergen and the DLA, valued up to $999,999,999, for the supply of a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. The contract does not have a set-aside designation and is intended to provide the Cosentyx medication to support federal healthcare requirements.

Generated 10/16/24, 9:25 AM